High-Glo Equine IgGThis page contains information on High-Glo Equine IgG for veterinary use.
The information provided typically includes the following:
- High-Glo Equine IgG Indications
- Warnings and cautions for High-Glo Equine IgG
- Direction and dosage information for High-Glo Equine IgG
High-Glo Equine IgGThis treatment applies to the following species:
(for veterinary use only)
High-Glo Equine IgG is an intravenous treatment for failure of passive transfer for neonatal foals. Dose at a rate of 20ml/kg of body weight (approximately 10 ml/pound). High-Glo Equine IgG is collected in a sterile closed system from healthy horses testing negative for the antibodies against Aa, Ca, and Qa red cell antigens. Sodium citrate is used as an anticoagulant as part of the manufacturing process. High-Glo Equine IgG is frozen immediately after collection and as such does not contain preservatives.
Use: High-Glo Equine IgG requires freezing until used. To thaw, submerge the frozen IgG in warm water (<115°F) for 10 minutes, squeezing the bag periodically to circulate for faster thawing. Warm the liquid plasma to body temperature, again, using a warm water bath. Do not microwave this product!
Administer using an IV administration kit with filter. Caution should be observed however, as occasionally intravenous infusion may result in shaking, sweating or hyperventilation. If this occurs, discontinue use for 5-10 minutes. Then resume at a slower rate of infusion. If adverse reactions persist, discontinue use.
Caution: There is always the possibility, while rare, of transmission of viral disease in any blood product.
U.S. Vet. Lic. No. 614
Mg Biologics, 1721 Y Ave, Ames, IA 500014
NAC No.: 12600003
2366 270TH ST., AMES, IA, 50014
|Every effort has been made to ensure the accuracy of the High-Glo Equine IgG information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 Animalytix LLC. Updated: 2018-09-28